US Broker Ratings

Denali Therapeutics Inc. (DNLI) Stock Analysis: Navigating the Biotech Terrain with a 54.52% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating neurodegenerative and lysosomal storage diseases...

Schrodinger, Inc. (SDGR) Investor Outlook: Exploring an 81% Potential Upside Amidst Healthcare Innovations

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the realm of health information services. Headquartered in..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Assessing a 41.72% Potential Upside

As the medical devices sector continues to innovate, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out with its focus on improving the lives of diabetes patients..

Addus HomeCare Corporation (ADUS): Investor Outlook with a 36% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling player in the healthcare sector, specifically within the Medical Care Facilities industry. With a market capitalization..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring Growth Potential Amidst a 16.9% Revenue Surge

Twist Bioscience Corporation (NASDAQ: TWST), a pioneer in synthetic DNA production, remains a compelling investment opportunity in the healthcare sector, particularly within diagnostics and research. Headquartered..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unraveling a 42.71% Potential Upside in Precision Medicine

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has captured the attention of investors with its focus on precision medicine within the biotechnology sector. Headquartered in South San Francisco,..

PACS Group, Inc. (PACS) Investor Outlook: A Promising 36% Upside in the Healthcare Sector

PACS Group, Inc. (NASDAQ: PACS) has emerged as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Focused on providing skilled..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a Promising 41% Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector, with a focus on innovative solutions for neurological and rare diseases. With a market capitalization..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Biotech Growth with a 39.77% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling opportunity for investors with its strong growth trajectory in the biotechnology sector, a promising pipeline of drug candidates,..

Organon & Co. (OGN) Stock Analysis: Navigating the 37.83% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN), a healthcare company specializing in women’s health solutions and biosimilars, presents an intriguing opportunity for investors willing to navigate its current..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 26.69% Potential Upside in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is carving out a niche in the biotechnology sector with its innovative approach to eye care and disease prevention. Investors are..

HUTCHMED (China) Limited (HCM) Stock Analysis: Navigating the 55.60% Potential Upside Amidst Revenue Challenges

HUTCHMED (China) Limited (HCM) is attracting significant attention from investors as it boasts a promising potential upside of 55.60% according to analysts’ average target price. Despite..

Beam Therapeutics Inc. (BEAM): Investor Outlook on a Biotech with 80% Upside Potential

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector with its robust pipeline of precision genetic medicines, targeting serious diseases through innovative therapies. Founded..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 175% Potential Upside

Investors are taking a keen interest in Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, as it continues to make waves in the biotechnology sector...

Privia Health Group, Inc. (PRVA): Analyst Consensus Highlights 36.7% Upside Potential

For investors keen on tapping into the healthcare sector’s burgeoning technology and services segment, Privia Health Group, Inc. (NASDAQ: PRVA) presents a compelling opportunity. The company’s..

CG Oncology, Inc. (CGON) Stock Analysis: Unpacking a 31% Potential Upside in Biotech’s Hot Sector

As CG Oncology, Inc. (CGON) continues to make waves in the healthcare sector, particularly within the biotechnology industry, investors are taking a keen interest in its..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 28% Upside Potential in Biotech

PTC Therapeutics, Inc. (NASDAQ: PTCT) is making waves in the biotechnology sector, offering investors an intriguing opportunity given its current market positioning and growth prospects. With..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 12.76% Potential Upside in the Healthcare Sector

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector with a market capitalization of $2.56 billion, operates at the intersection of medical instruments..

Veracyte, Inc. (VCYT): Investor Outlook Highlights 42% Potential Upside

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector specializing in diagnostics and research, is currently capturing the attention of investors thanks to a..

Progyny, Inc. (PGNY) Investor Outlook: Exploring a 56.91% Potential Upside in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) stands out in the healthcare sector as a prominent player in the niche market of fertility and family-building benefits. For investors seeking..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds